DK1458364T3 - Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus - Google Patents

Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus

Info

Publication number
DK1458364T3
DK1458364T3 DK02791739T DK02791739T DK1458364T3 DK 1458364 T3 DK1458364 T3 DK 1458364T3 DK 02791739 T DK02791739 T DK 02791739T DK 02791739 T DK02791739 T DK 02791739T DK 1458364 T3 DK1458364 T3 DK 1458364T3
Authority
DK
Denmark
Prior art keywords
glibenclamide
metformin
treatment
type
pharmaceutical compositions
Prior art date
Application number
DK02791739T
Other languages
Danish (da)
English (en)
Inventor
Alessandro Tosetti
Mauro Guiducci
Giovanni Viti
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1458364(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Application granted granted Critical
Publication of DK1458364T3 publication Critical patent/DK1458364T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02791739T 2001-11-29 2002-11-29 Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus DK1458364T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001FI000230A ITFI20010230A1 (it) 2001-11-29 2001-11-29 Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
PCT/EP2002/013497 WO2003045355A1 (en) 2001-11-29 2002-11-29 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus

Publications (1)

Publication Number Publication Date
DK1458364T3 true DK1458364T3 (da) 2008-06-23

Family

ID=11442301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02791739T DK1458364T3 (da) 2001-11-29 2002-11-29 Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus

Country Status (40)

Country Link
US (1) US20050053661A1 (de)
EP (1) EP1458364B1 (de)
JP (1) JP4474162B2 (de)
KR (1) KR20040079898A (de)
CN (1) CN1596103B (de)
AR (1) AR037407A1 (de)
AT (1) ATE387190T1 (de)
AU (1) AU2002358061B2 (de)
BR (1) BR0214403A (de)
CA (1) CA2466677A1 (de)
CO (1) CO5590906A2 (de)
CY (1) CY1107966T1 (de)
DE (1) DE60225331T2 (de)
DK (1) DK1458364T3 (de)
EA (1) EA006766B1 (de)
EG (1) EG24124A (de)
ES (1) ES2302862T3 (de)
HK (1) HK1069974A1 (de)
HN (1) HN2002000341A (de)
HR (1) HRP20040501A2 (de)
HU (1) HUP0402154A3 (de)
IL (1) IL162143A0 (de)
IT (1) ITFI20010230A1 (de)
MA (1) MA27087A1 (de)
MX (1) MXPA04004974A (de)
MY (1) MY141243A (de)
NO (1) NO20042713L (de)
NZ (1) NZ533779A (de)
PA (1) PA8559801A1 (de)
PE (1) PE20030580A1 (de)
PL (1) PL206016B1 (de)
PT (1) PT1458364E (de)
RS (1) RS50937B (de)
SI (1) SI1458364T1 (de)
SV (1) SV2004001415A (de)
TN (1) TNSN04095A1 (de)
UA (1) UA81615C2 (de)
UY (1) UY27549A1 (de)
WO (1) WO2003045355A1 (de)
ZA (1) ZA200404880B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2725833A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
KR100897890B1 (ko) 2002-06-17 2009-05-18 인벤티아 헬스케어 피브이티. 엘티디. 티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
ES2303085T3 (es) 2003-04-29 2008-08-01 Orexigen Therapeutics, Inc. Composiciones que afectan a la perdida de peso.
PE20061245A1 (es) * 2005-03-30 2007-01-06 Generex Pharm Inc Composiciones para la transmision transmucosa oral de la metformina
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
KR20190042766A (ko) * 2006-11-09 2019-04-24 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
MX2010012909A (es) 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
AU2011203867B2 (en) 2010-01-11 2015-12-03 Nalpropion Pharmaceuticals Llc Methods of providing weight loss therapy in patients with major depression
RU2483717C2 (ru) * 2010-11-22 2013-06-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения диабета (варианты)
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
US20120177730A1 (en) 2011-01-07 2012-07-12 Elcelyx Therapeutics, Inc. Chemosensory Receptor Ligand-Based Therapies
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
AU2012363873B2 (en) 2012-01-06 2017-11-23 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
JP6175074B2 (ja) 2012-01-06 2017-08-02 エルセリクス セラピューティクス インコーポレイテッド 代謝障害を治療するための組成物および方法
EP2858640B1 (de) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Zusammensetzung zur Verwendung in einem Verfahren zur Behandlung von Übergewicht und Fettleibigkeit in Patienten mit hohem Herz-Kreislauf-Risiko
WO2016076280A1 (ja) 2014-11-11 2016-05-19 塩野義製薬株式会社 光に対して不安定な薬物を含有する多層錠剤
KR101750690B1 (ko) * 2015-10-28 2017-06-27 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) * 2015-12-23 2016-05-25 青岛海之源智能技术有限公司 一种二甲双胍阿昔莫司复方组合物及制备方法
CN110128305A (zh) * 2019-05-10 2019-08-16 天津大学 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
CN1203846C (zh) * 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
PT974356E (pt) * 1998-07-15 2004-02-27 Merck Sante Sas Comprimidos compreendendo uma combinacao de metformina e de glibenclamida
US6780432B1 (en) * 2000-05-01 2004-08-24 Aeropharm Technology, Inc. Core formulation
CA2725833A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system

Also Published As

Publication number Publication date
IL162143A0 (en) 2005-11-20
NZ533779A (en) 2007-02-23
EG24124A (en) 2008-07-07
MY141243A (en) 2010-03-31
PE20030580A1 (es) 2003-09-05
KR20040079898A (ko) 2004-09-16
HRP20040501A2 (en) 2004-12-31
DE60225331T2 (de) 2009-02-26
CY1107966T1 (el) 2013-09-04
HUP0402154A3 (en) 2008-04-28
PL369851A1 (en) 2005-05-02
HN2002000341A (es) 2009-12-07
PL206016B1 (pl) 2010-06-30
HK1069974A1 (en) 2005-06-10
EA006766B1 (ru) 2006-04-28
UA81615C2 (ru) 2008-01-25
RS47304A (en) 2006-10-27
CN1596103B (zh) 2010-06-16
ES2302862T3 (es) 2008-08-01
TNSN04095A1 (en) 2006-06-01
HUP0402154A2 (hu) 2005-02-28
EA200400664A1 (ru) 2004-10-28
US20050053661A1 (en) 2005-03-10
MA27087A1 (fr) 2004-12-20
PA8559801A1 (es) 2003-06-30
AU2002358061A1 (en) 2003-06-10
CA2466677A1 (en) 2003-06-05
ZA200404880B (en) 2005-07-29
PT1458364E (pt) 2008-05-26
CO5590906A2 (es) 2005-12-30
AR037407A1 (es) 2004-11-10
WO2003045355A1 (en) 2003-06-05
JP2005518360A (ja) 2005-06-23
RS50937B (sr) 2010-08-31
EP1458364A1 (de) 2004-09-22
EP1458364B1 (de) 2008-02-27
ITFI20010230A1 (it) 2003-05-29
AU2002358061B2 (en) 2007-01-11
NO20042713L (no) 2004-07-16
CN1596103A (zh) 2005-03-16
SI1458364T1 (sl) 2008-08-31
DE60225331D1 (de) 2008-04-10
JP4474162B2 (ja) 2010-06-02
MXPA04004974A (es) 2004-08-11
BR0214403A (pt) 2004-10-19
SV2004001415A (es) 2004-05-07
UY27549A1 (es) 2003-06-30
ATE387190T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
DK1458364T3 (da) Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
DK1412357T3 (da) Beta-aminotetrahydroimidazo-(1,2-a)-pyraziner og tetrahydrotriazolo-(4,3-a)-pyraziner som dipeptidylpeptidaseinhibitorer til behandling eller forebyggelse af diabetes
DK1309324T3 (da) Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
NO20033566D0 (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
DK1380209T3 (da) Sammensætning til et middel til bekæmpelse af skadelige organismer og fremgangsmåde til anvendelse af samme
HUP0401665A3 (en) Alfa and beta-form crystal of an aminothiazolyl acetanilide derivative, their use and pharmaceutical compositions containing them
DK1572707T3 (da) Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
ATE303802T1 (de) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phen l enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
NO20033100D0 (no) Uorganiske matrikssammensetninger og kompositter som inneholder matrikssammensetningen
DE50311318D1 (de) Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
ATE296302T1 (de) 4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1395242T3 (da) Flydende farmaceutisk sammensætning
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
DK0991654T3 (da) Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
DK1170281T3 (da) 1,1- og 1,2-disubstituerede cyclopropaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
EE200300563A (et) Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim